Skip to main content

Advertisement

SpringerLink
Log in

Human Umbilical Cord Mesenchymal Stem Cells-derived Exosomal lncRNA FAM99B Represses Hepatocellular Carcinoma Cell Malignancy

  • Original Paper
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Human umbilical cord mesenchymal stem cell (hucMSC)-derived exosomes (Exo) have been frequently investigated for disease control. This study was designed to explore the effects of hucMSC-Exo carrying lncRNA family with sequence similarity 99-member B (Exo-lncRNA FAM99B) on hepatocellular carcinoma (HCC) cell behaviour. The expression of lncRNA FAM99B in HCC cells was measured by reverse-transcription quantitative polymerase chain reaction. Protein levels of exosomal markers were quantified using western blotting. Flow cytometry analyses were performed to detect surface markers of hucMSCs and to measure the effects of Exo-lncRNA FAM99B on HCC cell cycle progression and cell apoptosis. Nanoparticle tracking analysis was used to measure the particle size of the exosomes. Additionally, cell viability was evaluated using methyl thiazolyl tetrazolium assays, and Transwell assays were performed to measure cell migration and invasion. Xenograft tumor models were established to explore the role of Exo-lncRNA FAM99B in vivo. Experimental results revealed that lncRNA FAM99B was downregulated in HCC cell lines, and low level of FAM99B is associated with poor survival rates in patients with HCC according to bioinformatics analysis. HucMSCs were identified in a good morphology with positively expressed CD105, CD29, and CD44 as well as negatively expressed CD31, CD14, and HLA-DR. High protein levels of exosomal markers (Alix, CD63 and TSG101) identified the existence of HucMSC-Exo. Importantly, the hucMSCs-Exo could enter HCC cells and exerted a suppressive effect on malignant cell activities. Moreover, overexpression of Exo-lncRNA FAM99B enhanced cell cycle arrest and cell apoptosis while suppressing cell viability, migration, and invasion in HCC. Exo-siRNA-FAM99B exerted the opposite effects on HCC cell process. In vivo experiments verified that Exo-lncRNA FAM99B inhibited tumorigenesis in HCC. In summary, lncRNA FAM99B derived from hucMSC-Exo inhibited malignant cellular phenotypes and tumorigenesis in HCC, which might provide a novel therapeutic strategy for HCC treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Shimada, S., Mogushi, K., Akiyama, Y., Furuyama, T., Watanabe, S., Ogura, T., Ogawa, K., Ono, H., Mitsunori, Y., Ban, D., Kudo, A., Arii, S., Tanabe, M., Wands, J. R., & Tanaka, S. (2019). Comprehensive molecular and immunological characterization of hepatocellular carcinoma. EBioMedicine, 40, 457–470.

    Article  PubMed  Google Scholar 

  2. Li, Y., Chen, B., Yang, X., Zhang, C., Jiao, Y., Li, P., Liu, Y., Li, Z., Qiao, B., Bond Lau, W., Ma, X. L., & Du, J. (2019). S100a8/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to Ischemic/Reperfusion Injury. Circulation, 140, 751–764.

    Article  CAS  PubMed  Google Scholar 

  3. Liu, Y., Sun, L., Gao, F., Yang, X., Li, Y., Zhang, Q., Zhu, B., Niu, S., Huang, Y., Hu, Y., Feng, Y., Jiang, Y., & Wang, X. (2018). A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma. Medicine (Baltimore).97,e13536.

  4. Cheng, S., Chen, M., Cai, J., Sun, J., Guo, R., Bi, X., Lau, W. Y., & Wu, M. (2020). Chinese Expert Consensus on Multidisciplinary diagnosis and treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer, 9, 28–40.

    Article  PubMed  Google Scholar 

  5. Pan, W., Li, W., Zhao, J., Huang, Z., Zhao, J., Chen, S., Wang, C., Xue, Y., Huang, F., Fang, Q., Wang, J., Brand, D., & Zheng, S. G. (2019). lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Molecular Oncology, 13, 2246–2258.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Marchese, F. P., & Huarte, M. (2017). A long noncoding RNA in DNA replication and chromosome dynamics. Cell Cycle, 16, 151–152.

    Article  CAS  PubMed  Google Scholar 

  7. Sheng, J. Q., Wang, M. R., Fang, D., Liu, L., Huang, W. J., Tian, D. A., He, X. X., & Li, P. Y. (2021). LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. Biomedicine & Pharmacotherapy, 133, 111023.

    Article  CAS  Google Scholar 

  8. Chen, Y. T., Xiang, D., Zhao, X. Y., & Chu, X. Y. (2021). Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m(6)a methylation promotes disease progression and sorafenib resistance. Human Cell, 34, 1800–1811.

    Article  CAS  PubMed  Google Scholar 

  9. Xu, K., Xia, P., Gongye, X., Zhang, X., Ma, S., Chen, Z., Zhang, H., Liu, J., Liu, Y., Guo, Y., Yao, Y., Gao, M., Chen, Y., Zhang, Z., & Yuan, Y. (2022). A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression. Mol Metab, 63, 101540.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Fagerberg, L., Hallström, B. M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., Habuka, M., Tahmasebpoor, S., Danielsson, A., Edlund, K., Asplund, A., Sjöstedt, E., Lundberg, E., Szigyarto, C. A., Skogs, M., Takanen, J. O., Berling, H., Tegel, H., Mulder, J., Nilsson, P., Schwenk, J. M., Lindskog, C., Danielsson, F., Mardinoglu, A., Sivertsson, A., von Feilitzen, K., Forsberg, M., Zwahlen, M., Olsson, I., Navani, S., Huss, M., Nielsen, J., Ponten, F., & Uhlén, M. (2014). Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular And Cellular Proteomics, 13, 397–406.

    Article  CAS  PubMed  Google Scholar 

  11. Mo, M., Liu, S., Ma, X., Tan, C., Wei, L., Sheng, Y., Song, Y., Zeng, X., Huang, D., & Qiu, X. (2019). A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion. Journal Of Cancer Research And Clinical Oncology, 145, 2027–2038.

    Article  CAS  PubMed  Google Scholar 

  12. Uccelli, A., Moretta, L., & Pistoia, V. (2006). Immunoregulatory function of mesenchymal stem cells. European Journal Of Immunology, 36, 2566–2573.

    Article  CAS  PubMed  Google Scholar 

  13. Zeddou, M., Briquet, A., Relic, B., Josse, C., Malaise, M. G., Gothot, A., Lechanteur, C., & Beguin, Y. (2010). The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biology International, 34, 693–701.

    Article  PubMed  Google Scholar 

  14. Raio, L., Cromi, A., Ghezzi, F., Passi, A., Karousou, E., Viola, M., Vigetti, D., De Luca, G., & Bolis, P. (2005). Hyaluronan content of Wharton’s jelly in healthy and down syndrome fetuses. Matrix Biology, 24, 166–174.

    Article  CAS  PubMed  Google Scholar 

  15. Prasanna, S. J., Gopalakrishnan, D., Shankar, S. R., & Vasandan, A. B. (2010). Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One, 5, e9016.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gauthaman, K., Yee, F. C., Cheyyatraivendran, S., Biswas, A., Choolani, M., & Bongso, A. (2012). Human umbilical cord Wharton’s jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. Journal Of Cellular Biochemistry, 113, 2027–2039.

    Article  CAS  PubMed  Google Scholar 

  17. Yuan, Y., Zhou, C., Chen, X., Tao, C., Cheng, H., & Lu, X. (2018). Suppression of tumor cell proliferation and migration by human umbilical cord mesenchymal stem cells: A possible role for apoptosis and wnt signaling. Oncol Lett, 15, 8536–8544.

    PubMed  PubMed Central  Google Scholar 

  18. Xu, Y., Lai, Y., Cao, L., Li, Y., Chen, G., Chen, L., Weng, H., Chen, T., Wang, L., & Ye, Y. (2021). Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10. Rna Biology, 18, 1408–1423.

    Article  CAS  PubMed  Google Scholar 

  19. Zhang, Z. G., Buller, B., & Chopp, M. (2019). Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nat Rev Neurol, 15, 193–203.

    Article  PubMed  Google Scholar 

  20. Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018). Extracellular vesicles in cancer - implications for future improvements in cancer care. Nature Reviews. Clinical Oncology, 15, 617–638.

    Article  CAS  PubMed  Google Scholar 

  21. Chen, C., Luo, Y., He, W., Zhao, Y., Kong, Y., Liu, H., Zhong, G., Li, Y., Li, J., Huang, J., Chen, R., & Lin, T. (2020). Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest, 130, 404–421.

    Article  CAS  PubMed  Google Scholar 

  22. Yeo, R. W., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013). Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Advanced Drug Delivery Reviews, 65, 336–341.

    Article  CAS  PubMed  Google Scholar 

  23. Gu, H., Yan, C., Wan, H., Wu, L., Liu, J., Zhu, Z., & Gao, D. (2021). Mesenchymal stem cell-derived exosomes block malignant behaviors of hepatocellular carcinoma stem cells through a lncRNA C5orf66-AS1/microRNA-127-3p/DUSP1/ERK axis. Human Cell, 34, 1812–1829.

    Article  CAS  PubMed  Google Scholar 

  24. Chen, L., Wang, Y., Li, S., Zuo, B., Zhang, X., Wang, F., & Sun, D. (2020). Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway. Theranostics, 10, 9425–9442.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Wang, G., Jin, S., Huang, W., Li, Y., Wang, J., Ling, X., Huang, Y., Hu, Y., Li, C., Meng, Y., & Li, X. (2021). LPS-induced macrophage HMGB1-loaded extracellular vesicles trigger hepatocyte pyroptosis by activating the NLRP3 inflammasome. Cell Death Discov, 7, 337.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Yan, C., Wei, S., Han, D., Wu, L., Tan, L., Wang, H., Dong, Y., Hua, J., & Yang, W. (2020). LncRNA HULC shRNA disinhibits mir-377-5p to suppress the growth and invasion of hepatocellular carcinoma in vitro and hepatocarcinogenesis in vivo. Ann Transl Med, 8, 1294.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Hong, H., Sui, C., Qian, T., Xu, X., Zhu, X., Fei, Q., Yang, J., & Xu, M. (2020). Long noncoding RNA LINC00460 conduces to tumor growth and metastasis of hepatocellular carcinoma through miR-342-3p-dependent AGR2 up-regulation. Aging (Albany NY), 12, 10544–10555.

    Article  CAS  PubMed  Google Scholar 

  28. He, X., Chen, J., Zhou, J., Mao, A., Xu, W., Zhu, H., Pan, Q., Zhao, Y., Zhang, N., Wang, L., Wang, M., Liu, Z., Zhu, W., & Wang, L. (2022). LncRNA-EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src-YAP signaling axis. Faseb j.36,e22663.

  29. Chen, J., Yuan, D., Hao, Q., Zhu, D., & Chen, Z. (2021). LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro. Adv Clin Exp Med, 30, 831–838.

    Article  PubMed  Google Scholar 

  30. Tian, J., & Hu, D. (2021). LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survival. Clin Res Hepatol Gastroenterol, 45, 101490.

    Article  CAS  PubMed  Google Scholar 

  31. Hewson, C., & Morris, K. V. (2016). Form and function of Exosome-Associated Long non-coding RNAs in Cancer. Current Topics In Microbiology And Immunology, 394, 41–56.

    PubMed  Google Scholar 

  32. Konečná, B., Tóthová, Ľ., & Repiská, G. (2019). Exosomes-Associated DNA-New marker in pregnancy complications? Int J Mol Sci 20.

  33. Han, F., Huang, D., Huang, X., Wang, W., Yang, S., & Chen, S. (2020). Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells. Journal Of Cellular And Molecular Medicine, 24, 7730–7742.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhuo, C., Yi, T., Pu, J., Cen, X., Zhou, Y., Feng, S., Wei, C., Chen, P., Wang, W., Bao, C., Wang, J., & Tang, Q. (2020). Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765. Aging (Albany NY).12,26236–26247.

Download references

Acknowledgements

Not applicable.

Author information

Authors and Affiliations

  1. Department of General Surgery, Nanjing Tongren Hospital, No. 2007, Jiyin Avenue, Jiangning District, Nanjing, 211102, China

    Gang Xu, Kunfeng Ban, Haifeng Mu & Baochen Wang

Authors
  1. Gang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kunfeng Ban
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haifeng Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baochen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baochen Wang.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary File: Statement of the study approval by the Institutional Review Board.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, G., Ban, K., Mu, H. et al. Human Umbilical Cord Mesenchymal Stem Cells-derived Exosomal lncRNA FAM99B Represses Hepatocellular Carcinoma Cell Malignancy. Mol Biotechnol 66, 1389–1401 (2024). https://doi.org/10.1007/s12033-023-00795-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-023-00795-y

Keywords

Search

Navigation